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Summary
Coeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by the
ingestion of gluten proteins from wheat, barley and rye. The a-gliadin gene family of wheat
contains four highly stimulatory peptides, of which the 33-mer is the main immunodominant
peptide in patients with coeliac. We designed two sgRNAs to target a conserved region adjacent
to the coding sequence for the 33-mer in the a-gliadin genes. Twenty-one mutant lines were
generated, all showing strong reduction in a-gliadins. Up to 35 different genes were mutated in
one of the lines of the 45 different genes identified in the wild type, while immunoreactivity was
reduced by 85%. Transgene-free lines were identified, and no off-target mutations have been
detected in any of the potential targets. The low-gluten, transgene-free wheat lines described
here could be used to produce low-gluten foodstuff and serve as source material to introgress
this trait into elite wheat varieties.
Introduction
Wheat is one of the most widely grown crops in the world and a
major component of the human diet. Wheat grain contains
gluten proteins, which are responsible for the unique viscoelastic
properties of wheat-derived foods; however, they also trigger
certain pathologies in susceptible individuals. Amongst these, the
a-gliadin family is the main protein group associated with the
development of coeliac disease and noncoeliac gluten sensitivity,
which affect more than 7% of the Western population (Must-
alahti et al., 2010; Sapone et al., 2011). In bread wheat,
a-gliadins are encoded by approximately 100 genes and pseudo-
genes (Ozuna et al., 2015) organized in tandem at the Gli-2 loci
of chromosomes 6A, 6B and 6D. Traditional mutagenesis and
plant breeding have failed to obtain low immunogenic wheat
varieties for patients with coeliac. Here, we show that CRISPR/
Cas9 technology can be used to precisely and efficiently reduce
the amount of a-gliadins in the seed kernel, providing bread and
durum wheat lines with reduced immunoreactivity for gluten-
intolerant consumers.
Results and discussion
To precisely modify the immunoreactive a-gliadin genes, we
designed two sgRNAs (sgAlpha-1 and sgAlpha-2) (Figure 1a) to
target conserved regions adjacent to the coding sequence for the
immunodominant epitope in wheat gluten, a protease-resistant,
33-amino acid peptide that contains six overlapping copies of
three distinct, tandemly organized epitopes (DQ2.5-glia-a1a,
PFPQPELPY; DQ2.5-glia-a2, PQPELPYPQ; and DQ2.5-glia-a1b,
PYPQPELPY) (Tye-Din et al., 2010). The CRISPR/Cas9 constructs
were transformed into two bread wheat (BW028 and TAH53)
and one durum wheat (DP) cultivars, resulting in twenty-one (15
bread wheat and 6 durum wheat) T0 transgenic lines. DNA was
isolated from leaves of 17 T1 transgenic plants (5 BW208, 4
TAH53, and 8 DP) and the corresponding wild-type varieties, and
PCR amplicons encompassing the sgAlpha-1 and sgAlpha-2
target sites were subjected to Illumina high-throughput DNA
sequencing (Figure 1a, Table S1). We observed considerable
variability in the bread wheat and durum wheat wild-type
sequences, due to randomly distributed SNPs and differences in
the number of encoded epitopes in the 33-mer region (Figure S1).
As expected, a number of sequences were pseudogenes with
premature stop codons, and frameshift mutations in the C-
terminus (Figure S2). We found 45, 52 and 43 different a-gliadin
sequences that were highly represented (frequencies higher than
0.3%) in BW208, THA53 and DP, respectively. Of these, 35, 13
and 29 were, respectively, mutated by CRISPR/Cas9 (Figure S3).
The mutation spectrum in the a-gliadins was characterized in the
various T1 transgenic plants (Figure 1b–d, Table S2, Figures S4–
S6). Due to the presence of the Cas9 expression vector in some of
the mutant lines, the frequency of mutations observed might be
overestimated, as a consequence of somatic mutations. However,
in most cases we observed similar mutation frequencies in T1
plants generated from the same T0 plant, with or without Cas9—
that is V467 (+Cas9, 5.18% NHEJ) and V468 (Cas9, 5.17%
NHEJ), both derived from T0 plant #20 (Table S2).
In general, sgAlpha-2 was more effective than sgAlpha-1. It
should be noted that lower regeneration was observed in
transgenic plants containing sgAlpha1 (0.3% transformation
frequency) than plants with sgAlpha2 (1% transformation
frequency). Therefore, a possible toxic effect might be also
affecting the NHEJ activity of sgAlpha-1, favouring the regener-
ation of those lines in which the level of expression of sgAlpha1
is lower, and consequently the mutation frequency. The highest
mutation frequencies (62.3%–75.1%) were observed in the
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Figure 1 Gene editing of a-gliadins in bread wheat. (a) Schematic of a typical a-gliadin gene indicating the different protein domains. Two of the peptide
sequences involved in gluten intolerance (p31-43 and the 33-mer) are represented by red arrows, whereas the target sequences for the sgRNAs (sgAlpha-1
and sgAlpha-2) are represented by blue arrows. Black arrows indicate primers used for Illumina sequencing. (b–d) Illumina sequencing of the a-gliadin genes
of 3 T1 BW208 mutant lines (T544, T545 and T553) transformed with sgAlpha-2. (b) Alignment of the different deletion types found at the target locus of
sgAlpha-2; (c) Alignment of the different insertions at the target locus of sgAlpha-2; and (d) frequency of the different type of insertions and deletions.
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BW208-derived lines transformed with sgAlpha-2 (Table S2).
Three of these T1 lines (T544, T545 and T553) had insertions and
deletions (indels) at the target site of between +36 and +158 bp
and 1 and 126 bp, respectively (Figure 1b–d). Line T545 had
the highest mutation frequency of all analysed lines: ~75% of
the sequence reads had indels (Table S2). Transgenic lines of cv
DP and cv THA53 showed lower indel frequencies, ranging
between 1.50% and 14.77% and 5.16%–7.86%, respectively.
Interestingly, the typical 1bp deletion normally observed with
CRISPR/Cas9 was very frequent in two of the DP sgAlpha-2 lines
(22.4%–35.6%), but only represented 0.18%–2.9% of the
mutations found in the BW208 sgAlpha-2 lines (Figures 1 and
S4). The 1bp deletion was not found in the THA53 lines or in
the sgAlpha-1 lines. The +1 bp insertion, also reported as a
typical mutation of CRISPR/Cas9, was only found at low
frequency in one of the sgAlpha-1 lines. A possible explanation
for this observation is the preference of certain types of deletions
due to microhomology-mediated repair. The target sites of
sgAlpha-1 and sgAlpha-2 are highly repetitive, and as shown in
Figure S7, repeats between 3 and 36 bp are commonly found
flanking the targeted break. The repeats could explain the bias in
favour of some of the most frequent mutations observed, such as
the 75 and 11 bp deletions in BW208 sgAlpha-2 lines, the
15 bp deletion in DP sgAlpha-2 lines and the 36 bp deletion
in all BW208, TAH53 and DP lines. DNA insertions represented
up to 19% of the total indels (Line T544, Table S2), and they
were found to be either fragments of the transformation vectors
or other a-gliadin genes, probably inserted by microhomology-
mediated repair. These results demonstrate that high mutation
frequency and specificity can be achieved using CRISPR/Cas9 to
modify complex genomic loci such as the a-gliadin gene family in
bread and durum wheat.
To assess the impact of the observed mutations on seed protein
composition, gliadin and glutenin content in T1 half-seeds was
qualitatively assessed by A-PAGE and SDS-PAGE, respectively
(Figures 2a,c and S8). In A-PAGE and SDS-PAGE gels, some tracks
are not contiguous and have been combined from different, or
the same gels (white lines) for presentation clarity. A-PAGE
demonstrated that a-gliadins were strongly reduced in some of
the bread and durum wheat T1 lines (e.g. plants # 6, 10, 12, 15,
17, 32 and 50), and partially reduced in others (e.g. plants # 14,
21, 28 and 48). The c- and x-gliadins were also strongly
decreased in some lines (e.g. plants # 6, 10, 12, 15 and 21).
Additional, novel bands, especially in the region of the gel
corresponding to the a-gliadins, were clearly visible in the A-PAGE
gels, perhaps due to truncation of a-gliadin coding sequences by
mutation (Figure S8). In addition, an accumulation of one mid-
range x-gliadin was observed in Plant 10 (Figures 2a and S8).
Mass spectrometry (MALDI-TOF) confirmed the sharp reduction
of a-gliadins in both sgAlpha-1 and sgAlpha-2 lines, with the
sgAlpha-2 lines showing a greater reduction in the number of
visible peaks (Figure 2b,d). As suggested by the Illumina sequenc-
ing results, sgAlpha-2 more effective reduced the a-gliadin
content, particularly in the BW208 bread wheat lines. The
glutenin profile for all lines was comparable to that of the wild
type; however, differences in the intensity of the two glutenin
fractions were observed, suggesting a mechanism for compen-
satory reduction in the abundance of these proteins in response
to the reduction of a-gliadins (Figure S8).
Encouraged by these results, HPLC analysis was performed to
accurately quantify and characterize the different groups of
gliadins and glutenins (Figure 2, Table S3). As expected, a-gliadin
content was significantly reduced in most of the transgenic lines
compared to the wild type (32%–82% reduction), especially in
the bread and durum wheat lines transformed with sgAlpha-2.
The c-gliadins were also significantly reduced by 25%–94% in 15
of the 18 T1 lines analysed, whereas the x-gliadins showed the
greatest variability: x-gliadins were not affected in all four durum
wheat lines, significantly up-regulated (twofold–threefold) in all
four bread wheat sgAlpha-1 T1 lines (Figure 2e), and down-
regulated by 33% in bread wheat Plant 10. Interestingly, this line
had the highest reduction in a-gliadins (82%) and c-gliadins
(92%) and consequently showed the highest overall gliadin
reduction (82%). Amongst the durum wheat lines, Plant 2 had
the highest overall gliadin reduction (69%). The reduction in the
gliadin content promoted a compensatory effect in glutenins,
increasing the HMW fraction, especially in the BW208 and THA53
bread wheat lines (Table S3). The LMW fraction was significantly
reduced only in Plant 10 and 32. Similar compensatory effects
were observed previously (Gil-Humanes et al., 2011) in wheat
lines in which the a-, c- and x-gliadins were down-regulated by
RNAi. In those RNAi lines, compensatory effects provided wheat
lines with no difference in the total protein content; however,
changes in seed protein expression had important implications on
the properties of the flour (Gil-Humanes et al., 2014b), as higher
glutenin contents, particularly HMWs, are usually associated with
stronger flours. The lines reported here show reduced total
gliadin content (specifically the a-gliadins containing the 33-mer
epitope), increased HMW glutenins and lower gli/glu ratios than
the wild type.
To confirm that the altered gliadin content effectively reduced
the immune reactivity of the flour, we analysed the T2 seeds of
the mutant lines with the monoclonal antibodies (mAb) R5 and
G12 (Figure 3). R5 is the mAb of choice in the food industry to
quantify gluten content and detects a conserved domain (QQPFP)
found in most gliadins (not only the ones that are immune
reactive) (Valdes et al., 2003). The G12 mAb is more specific for
detecting reactive epitopes, as it was developed against the 33-
mer peptide (Moron et al., 2008). ELISA tests with both mAbs
showed a strong reduction in gluten content in the sgAlpha-2-
derived lines compared to that of the BW208 wild type. In those
lines, we observed up to 85% reduction in gluten content (Line
T546), and an average reduction of 66.7% and 61.7%, respec-
tively, with the R5 and G12 mAbs. However, both mAbs revealed
an increase in the gluten content for lines with sgAlpha-1. These
two lines have a higher x-gliadin content—a consequence of the
knock-down of the a-gliadins (Tables S3 and S4)—which could
explain the observed increment in gluten content. Similar
increases in gluten content when only the c-gliadins were
down-regulated by RNAi were previously reported (Gil-Humanes
et al., 2008). In total, these results demonstrate that gluten
immunoreactivity can be significantly reduced by editing the a-
gliadin genes containing the immunodominant 33-mer epitope.
Once we had demonstrated the high efficiency of CRISPR/Cas9
to simultaneously mutate most of the a-gliadin genes, we
next asked whether off-target mutations were occurring at other
sites due to sgAlpha-1- and sgAlpha-2-mediated cleavage. First,
we looked for possible off-target mutations in the c- and
x-gliadin genes, as these proteins were reduced in the mutant
lines. Sanger sequencing of fifty-seven clones containing c-
gliadin genes (Figure S9) and forty-three clones with x-gliadins
genes─ twenty-four x1,2-gliadins (Figure S10) and nineteen x5-
gliadins (Figure S11)—showed no off-target mutations. These
results were confirmed by in silico search of the sgAlpha-1 and
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Figure 2 Characterization of sgAlpha-1 and sgAlpha-2 mutant plants. (a) A-PAGE of gliadins from sg Alpha-1 T1 half-seeds (named as T566 and T567
lines) derived from T0 plant 14, and V323 and V343 (from T0 plant 77) and the corresponding wild-type lines BW208 and THA53. Migration of a-, c-, x-
gliadin protein bands are outlined by brackets (b) MALDI-TOF analysis of the same gliadin extract in (a) from T567 track and the BW208 wild type. Values
are in absolute intensity. Left axis corresponds to T567 and the right axis to the BW208 line. The corresponding range of masses (m/z) for a-, c-, x-gliadins
are indicated by arrows. (c) A-PAGE of gliadins from sgAlpha-2 T1 half-seeds (named as T544, T545 and T553 lines) from T0 plant 10, V491 and V496
(plant 17), T666, T668 and T670 (plant 2) and the wild-type lines BW208, THA53 and DP. (d) MALDI-TOF analysis of the same gliadin extracts in (a) from
T553 track (plant 10) and T558 (plant 12, Figure S8), and the BW208 wild type. (e) Bar graph of fold change of a-, c-, x- and total gliadin fractions in bread
and durum wheat transformed with sgAlpha-1 and sgAlpha-2. Values for each plant were normalized by values of the corresponding wild-type lines. Note
that A-PAGE analysis is not a quantitative test, and intensity differences observed in the gels might be explained in part by differences in the amount of
protein loaded and/or by differences in the staining/distaining process.
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sgAlpha-2 sequences (NGG PAM plus 12 nt seed sequence,
allowing for up to 2 mismatches) in the wheat prolamin genes
annotated in the GenBank (Figure S12a). Additional sequencing
of 11–16 clones of amplified LMW from 3 T1 mutant lines (T544,
T545 and T553) showed no mutation in the only potential target
site identified (Figure S12b). We therefore concluded that the
observed decrease in the c- and x-gliadins and the glutenins in
the mutant lines was not a consequence of off-target mutations.
Rather, we speculate that antisense a-gliadin sequences could be
expressed, resulting in the observed broad reduction in a-gliadin,
as well as the down-regulation of the other gliadin proteins.
Antisense sequences of a-gliadins could originate in the mutant
lines as a consequence of cleavage at two target sites and
inversion of the intervening DNA sequence. We tried to detect
such hypothetical inversions by predicting the inversion product
and performing PCR assays (data not shown); however, none
were detected in any of the tested lines.
Next, we expanded our search for off-target sites to the entire
bread wheat genome (Figure S12c). Amongst all potential off-
target sites (41 for sgAlpha1 and 50 for sgAlpha2), only four were
annotated genes: a putative MADS box transcription factor
(Traes_7BL_F621D9B9E), two genes with unknown function
(Traes_2AS_D659E88E9.1, Traes_2AS_8FCC59363.1) and one
gene with homology with a-gliadins (Traes_4AL_4FF5B8837).
No mutations were identified in any of these genes in approx-
imately 10 clones sequenced from each gene in the T1 mutant
lines T544 (Figure S12d), T545 and T553. Collectively, these
results demonstrate the high specificity of the sgRNAs designed
to target the a-gliadins. Further characterization of potential off-
target sites in other nonannotated genes in the genome would be
necessary to confirm the lack of undesired mutations.
We next examined whether the mutations were transmitted to
the next (T2) generation. Illumina sequencing of 29 T2 plants,
with and without Cas9, showed heritability of the mutations
(Table S4). Confirming our observations in the T1 generation, the
presence/absence of the Cas9 expression vector in T2 plants did
not affect the mutation frequencies (Table S4), and we believe
that the variability observed between different lines can be
explained by (i) stable and somatic mutagenesis due to activity of
Cas9 and (ii) segregation of heterozygous stable mutations
produced in the previous generations. T2 lines derived from T0
plant #10 were selected for sequencing because they had the
least amount of integrated DNA at the cut sites.
The phenotype observed in the prolamin (gliadins and
glutenins) content was also inherited, as assessed by evaluating
25 different T2 lines (Table S5), and 16 T3 lines (Table S6) by RP-
HPLC. This demonstrated that the low-gluten trait is stable and
heritable, and will enable its introgression into elite wheat
varieties. As observed in T1 seeds, the HMW glutenins were also
increased in T2 and T3 seeds of mutant lines (Tables S5 and S6).
The HMW fraction is a major determinant of the functionality of
wheat flour. We assessed the bread-making quality of the mutant
lines using the SDS sedimentation test by bulking T2 and T3 seeds
from each line (Figure 3b). Although some mutant lines showed
higher SDS values (higher quality) than the wild-type control, we
observed significant reductions in the SDS values (lower quality) in
the mutant lines with the greatest reduction of gliadins. However,
in most cases, SDS values in the sgAlpha2 lines were comparable
to those of some RNAi lines previously reported showing 97%
reduction in the gluten content (Gil-Humanes et al., 2010). Flour
from those low-gluten RNAi lines showed increased stability and
better tolerance to over-mixing (Gil-Humanes et al., 2014b) and
allowed the production of bread with baking and sensory
properties comparable to those of normal wheat flour (Gil-
Humanes et al., 2014a). Consequently, one might expect that
mutant lines reported here will produce flour of a good quality
and bread-making performance.
Finally, we tested whether any of the low-gluten wheat lines
we generated were transgene- and insertion-free (i.e. lacked
insertions at the cleavage site). We screened the T1 and T2
wheat lines by PCR and Illumina high-throughput sequencing for
the presence of plasmid DNA (Figure S14). Three bread wheat
(BW208) and six durum wheat (DP) T2 plants were identified as
transgene-free and insertion-free (Figure S14). These nontrans-
genic lines showed reduction in a-gliadins (Figures 3c,d, and
S15) showing. In all cases, all T0, T1 and T2 generations of
sgAlpha-1 and sgAlpha-2 mutant bread and durum wheat were
fully fertile and set seeds, and had normal chromosome
numbers (Figure 3c).
We modified the coeliac disease-causing a-gliadin gene array
using CRISPR/Cas9 technology to obtain nontransgenic, low-
gluten wheat lines. Because of the complexity of the Gli-2 locus
and the high copy number of the a-gliadin genes, traditional
plant breeding and mutagenesis have failed to achieve low-
gluten wheat. However, CRISPR/Cas9 efficiently and precisely
targeted conserved regions of the a-gliadin genes in both bread
and durum wheat, leading to high-frequency mutagenesis in
most gene copies. Immunoreactivity of the CRISPR-edited wheat
lines was reduced by 85%, as revealed the R5 and G12 ELISA
tests. We previously reported the down-regulation of gliadin
genes by RNAi (Gil-Humanes et al., 2010) (Barro et al., 2016).
Both CRIPSR/Cas9 and RNAi are highly effective for obtaining
wheat lines lacking coeliac disease epitopes. However, the main
advantages of the CRISPR knockouts vs RNAi are that (i) CRISPR
knockouts are stable and heritable mutations that do not involve
the expression of a transgene, and (ii) therefore, they provide a
phenotype that is independent of environmental conditions. In
addition, CRISPR/cas9 would allow different strategies to that
reported in this work, that is cutting larger chromosome
fragments containing gliadin genes, or even more, replacement
of highly immunogenic fragments with others less toxic, keeping
the gliadins functionality. In contrast, to obtain all gliadin genes
mutated by CRISPR/Cas9, subsequent rounds of mutagenizing
will be needed using specific sgRNAs to target the remaining
gliadin genes. The low-gluten, transgene-free wheat lines
described here constitute an unprecedented advance, and the
resultant lines provide excellent source material for plant breed-
ing programmes to introgress the low-gluten trait into elite
wheat varieties.
Methods
sgRNAs design and plasmid construction
CRISPR/Cas9 reagents were cloned into the pANIC-6E destination
vector (Mann et al., 2012) downstream the Ubiquitin1 promoter
from maize. Two sgRNAs (sgAlpha-1: GCCACAAGAGCAAGTT
CCAT and sgAlpha-2: GGTTGTGATGGAAATGGTTG) were
designed to recognize conserved regions in the coding sequence
of a-gliadins in hexaploid wheat. To synthesize the expression
vectors pANIC-CR-Alpha1 and pANIC-CR-Alpha2, two Gateway-
compatible donor vectors, one containing TaCas9 (pGdonor-
TaCas9) and another containing the sgRNA (pGdonor-sgAlpha1
or pGdonor-sgAlpha2), were combined with pANIC-6E in a
multisite Gateway recombination reaction (Figure S13). pGdonor-
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TaCas9 contained a wheat-codon optimized Cas9 sequence
(TaCas9), with an N- and C-terminal nuclear localization signals
(NLS) from the simian vacuolating virus 40 (SV40) and nucleo-
plasmin, respectively, and the OCS terminator sequence. pGdo-
nor-sgAlpha contained the Triticum aestivum U6 RNA polymerase
III promoter (TaU6) for expression of the sgRNA, followed by the
gRNA sequence (Figure S13).
Plant material and genetic transformation
Transgenic lines were produced using immature scutella as
explants for genetic transformation as described previously
(Piston et al., 2009). Two bread wheat lines, denoted BW208
and THA53, and one durum wheat line, cv Don Pedro (DP),
were used as sources for scutellum isolation and in vitro
culture. Plasmids carrying the sgRNAs were precipitated onto
0.6-lm gold particles at 0.75 pmol/mg gold. Regeneration
medium was supplemented with 2 mg/L of PPT for selecting
transgenic plants. Putative transgenic plants were then trans-
ferred to soil and grown to maturity in the greenhouse, and
the presence of transformation vectors was confirmed by PCR
(Table S1).
Polyacrylamide gel electrophoresis analysis
Between 6 and 12 mature wheat grains per line were crushed
into a fine powder and used to extract sequentially the
endosperm storage proteins. Gliadins and glutenins were then
separated in A-PAGE and SDS-PAGE gels as described
(Gil-Humanes et al., 2012).
Reversed-phase high-performance liquid
chromatography (RP-HPLC)
Gliadins and glutenins were extracted and quantified by RP-HPLC
following the protocol reported (Piston et al., 2011). Ten half-
seed biological replications were carried out for each transgenic
line and wild type. Protein content was expressed as lg protein/
mg flour. For each line, 10 half-grains were analysed.
Gluten content determination by competitive ELISA
Gluten content was determined by competitive ELISA assays using
two monoclonal antibodies; R5 and G12. Samples for R5 were
analysed at Centro Nacional de Biotecnologıa (CSIC, Campus of
Cantoblanco, 28049-Madrid) as described elsewhere (Valdes
et al., 2003). Samples for G12 were analysed as described
previously (Barro et al., 2016). Between three and five biological
replications for each line were carried out.
Sodium dodecyl sulphate (SDS) sedimentation test
The SDS sedimentation volume was determined as described
(Williams et al., 1986). Between two and four biological replica-
tions for each line were carried out.
DNA extraction and PCR conditions for Illumina
amplicon sequencing
The Illumina MiSeq system was used for amplicon sequencing
producing 2 9 280 paired-end reads. PCR amplification was
carried out using the forward primer aGli900F1 and the reverse
primer 33mer1R2_ok (Table S1) with following conditions: 94 °C
for1 min followedby30cycles at94 °Cfor15 s,62 °Cfor45 sand
72 °C for 1 min with final extension at 72 °C for 2 min. For PCR
amplification, 5 ng of DNA in a 25 lL volume reaction with the
following final concentrations: 19 FastStart buffer, 200 nM for-
ward and reverse primers, 200 lM dNTPmix, 1.25 units of FastStart
High Fidelity polymerase (RocheDiagnostics,Mannheim,Germany)
was used. Preparation of the Illumina amplicon library and
sequencing was carried out at the Unidad de Genomica Canto-
blanco of Fundacion Parque Cientıfico de Madrid (FPCM, Spain).
The range of amplicon lengths was check using the Agilent 2100
Bioanalyzer system (Agilent Technologies, Santa Clara, CA 95051).
Amplicon sequence clustering
Fifty-three samples were subjected to amplicon sequencing: six
samples corresponded to wild-type DNA (2 BW208, 2 DP and 2
THA53), and 47 to DNA from transgenic lines (Tables S2 and S4). In
total, 33.817 millions of reads were obtained. For clustering, the
USEARCH software v8.0.1517 (Edgar, 2010) was used. Merging of
paired-end reads was using the -fastq_mergepairs command, and
for quality filtering by expected errors -fastq_filter (-fastq_maxee 1)
commandswere used (Edgar and Flyvbjerg, 2015). Then, all 11.676
millions of cleaned and filtered reads were clustered with -
cluster_otus mode, 100% homology and -search_exact command
for mapping and to extract the consensus sequence for each
cluster. To extract the high-confidence amplicon variants for each
sample, samples with less than five reads in a given cluster were
removed from that cluster. As clustering was at 100%, consensus
clusters were considered as unique genes. As samples have
different numbers of reads, frequencies were calculated for each
sample by dividing the number of reads for a given amplicon gene
(n) by the total count for a sample (N). Then, all gene sequences
were processed using Geneious version 9.1.4 (Biomatters Ltd.,
Auckland, New Zealand; available at http://www.gene-ious.com/).
First, a reference unique gene library was constructed for each of
the wild-type lines. Genes with different lengths were used as
reference sequences for aligning and mapping of amplicon genes
from mutant lines. Second, genes present in mutant lines were
aligned and mapped to reference gene library constructed previ-
ously using the BBmap aligner (https://sourceforge.net/projects/bb
map/). MAFFT software v7.222 (Katoh et al., 2002) and FastTree
software (Price et al., 2010) were used for multiple sequence
alignment and maximum-likelihood phylogenetic trees, respec-
tively, to determine the corresponding nonmutated sequences.
Figure 3 Analysis of Immune reactivity, SDS sedimentation volumes and gliadin profile of nontransgenic DP-derived lines, and phenotype of sgAlpha-
derived lines. (a) Analysis of T2 seeds of the sgAlpha-1 and sgAlpha-2 mutant lines with the monoclonal antibodies (mAb) R5 and G12. Error bars,
mean  SD. Statistically significant differences between each mutant line and the wild type were denoted *P < 0.05, **P < 0.01 (Tukey HSD all-pairwise
comparisons test) (b) Sodium dodecyl sulphate (SDS) sedimentation test expressed as mLg-1. T2 and T3 seeds from each line were bulked and three
independent biological replications analysed. Error bars, mean  SD. * Means are significantly different to wild types as determined by Dunnett’s multiple
comparisons at P < 0.05. (c) Content of the omega, alpha and gamma-gliadin fraction of the nontransgenic DP-derived lines. Error bars, 5% Confidence
Interval of the mean value of the wild-type DP line. (d) A-PAGE of gliadins from half-seeds of the nontransgenic DP-derived lines. Migration of a-, c-,
x-gliadin protein bands are outlined by brackets. (e) Spikes and seeds of sgAlpha-2 BW208 mutant line in comparison with its wild type. (f) Spikes and
seeds of sgAlpha-2 DP mutant line in comparison with its wild type.
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PCR amplification of c- and x-gliadin genes and
sequencing by Sanger
The gene-specific primers for Sanger sequencing of c- and
x-gliadin genes are in Table S1. These primers amplified from
signal peptide in the 50 to end of the coding region in the 30. The
complete c- and x-gliadin genes were amplified by PCR as follow:
94 °C for 4 min followed by 35 cycles at 94 °C for 15 s, 60 °C or
66 °C (c-gliadins and x-gliadins, respectively) for 1 min and 72 °C
for 1 min 30 s, with final extension at 72 °C for 7 min. For PCR
amplification, 200 ng of DNA in a 25 lL volume reaction consisting
of 400 nM forward and reverse primers, 320 lMdNTPmix, amixture
of 0.013 units Pfu DNA polymerase (Biotools, B&M Labs, Madrid,
Spain) and 0.650 units Taq DNA polymerase (Biotools) was used.
PCR products were checked by 1% agarose gel electrophoresis.
Full-length DNA sequences were ligated into pGEM-T Easy
vector (Promega, Madison, WI) and cloned into Escherichia coli
DH5a cells. Sequencing was carried out by Stab Vida
(Caparica, Portugal). We sequenced 102 clones (35 wild types
and 67 mutant lines) and 78 clones (26 wild types and 52 mutant
lines) for the c- and x-gliadin genes, respectively.
Detection of bar and Cas9 genes, and other DNA
plasmid regions
PCR was performed to detect insertions of plasmid DNA using
primers listed in Table S1. For detection of bar and Cas9 genes,
and PVS1 stability (sta) region, Octopine synthase polyA signal,
kanamycin resistance gene and Panicum virgatum ubiquitin 1
promoter, 300 ng of DNA was used in a 25 lL volume reaction,
consisting of 400 nM forward and reverse primers, 320 lM dNTP
mix and 0.650 units Taq DNA polymerase (Biotools, Madrid,
Spain). PCR conditions were as follows: 94 °C for 4 min followed
by 35 cycles at 94 °C for 15 s, 58 °C for 45 s or 30 s for Cas9
and the other genes, respectively, and 72 °C for 1 min 30 s with
final extension at 72 °C for 7 min.
Specifics primers (Table S1) were designed to be used with
aGli900 Forward primer for the amplification of each insertion
detected by deep sequencing. PCR conditions for the amplifi-
cation of insertions were as followed: 94 °C for 5 min followed
by 35 cycles at 94 °C for 30 s, 60 °C for 30 s and 72 °C for
30 s with a final extension at 72 °C for 5 min. For PCR
amplification, 300 ng of DNA in a 25 lL volume reaction
consisting of 400 nM forward and reverse primers, 320 lM
dNTP mix and 0.650 units Taq DNA polymerase (Biotools) was
used. All PCR products were checked by 1% agarose gel
electrophoresis.
Analysis of off-target mutations
Potential off-targets in the wheat genome were detected by
two different methods. First, we performed an in silico search
of the minimal active sequence of the sgRNAs in the prolamin
genes (except a-gliadins) deposited in the GenBank database
(http://www.ncbi.nlm.nih.gov/). We used the seed sequence (12
nt upstream the PAM sequence) of the sgAlpha-1 and sgAlpha-
2 plus the NGG PAM sequence and searched for homology in
179 c-gliadins, 15 x-gliadins, 40 HMW glutenins and 239
LMW glutenins, allowing up to two mismatches in the seed
sequence. Then, we expanded our in silico search for off-target
sites to the whole genome of wheat by searching for perfect
matches of the seed sequence (12 nt) plus PAM in the
reference genome of bread wheat (http://plants.ensembl.org/
index.html).
Potential off-targeted genes were characterized in 3 T1 mutant
plants (T544, T545 and T553). Specific primers were designed to
PCR amplify a 267 to 323 bp fragment encompassing the potential
off-target site of sgAlpha-1 or sgAlpha-2 in the identified genes
(Traes_7BL_F621D9B9E (MADS box transcription factor), Trae-
s_2AS_D659E88E9.1, Traes_2AS_8FCC59363.1 and the gene
family of LMW glutenins) (Table S1). Amplicons were cloned, and
between 24 and 39 clones were sequenced for each of the genes.
Matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) analysis
Gliadin fractions were extracted from wheat flours using 60%
ethanol for 1 h at room temperature in a rotary shaker and
centrifuged at 12000 g for 5 min at room temperature. Previ-
ously, samples were washed twice with 0.5 M NaCl for 30 min at
4 °C in a rotary shaker and centrifuged at 12000 g for 5 min at
4 °C, to remove albumins/globulins fraction.
The ethanolic supernatants obtained for each sample were
diluted at 1 : 1 ratio (v/v) with matrix solution (10 mg/mL 2,5
Dihydroxyacetophenone in 50% aqueous acetonitrile and
100 mM ammonium citrate). A 1.0 lL aliquot of this mixture
was manually deposited onto a 386-well OptiTOFTM Plate (Sciex)
and allowed to dry at room temperature. For MALDI-TOF/TOF
analysis, samples were automatically acquired in an ABi 4800
MALDI-TOF/TOF mass spectrometer (Sciex) in positive ion linear
mode (the ion acceleration voltage was 25 kV for MS acquisition).
The detection mass range was set between 1500 and 80 000 m/z.
Statistical analysis
Data were analysed with the statistical software Statistix v10
(Analytical software, PO Box 12185, Tallahassee, FL 32317). The
differences in the data were assessed using analysis of the
variance (ANOVA), followed by the two-tailed Dunnett’s post hoc
test for median multiple comparisons. P values lower than 0.05
were considered significant. Shapiro–Wilk normality test was
used to verify that data was normally distributed, and logarithmic
or Box Cox transformations were applied whenever a variable did
not pass the test. Figures were drawn using the Microsoft Excel
and PowerPoint software (Microsoft Corporation).
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